163 related articles for article (PubMed ID: 26985579)
1. Does valproic acid affect tumor growth and improve survival in glioblastomas?
Rudà R; Pellerino A; Soffietti R
CNS Oncol; 2016; 5(2):51-3. PubMed ID: 26985579
[No Abstract] [Full Text] [Related]
2. Valproic acid use during radiation therapy for glioblastoma associated with improved survival.
Barker CA; Bishop AJ; Chang M; Beal K; Chan TA
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):504-9. PubMed ID: 23523186
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide.
Redjal N; Reinshagen C; Le A; Walcott BP; McDonnell E; Dietrich J; Nahed BV
J Neurooncol; 2016 May; 127(3):505-14. PubMed ID: 26830093
[TBL] [Abstract][Full Text] [Related]
4. Valproic acid as the AED of choice for patients with glioblastoma? The jury is out.
Wen PY; Schiff D
Neurology; 2011 Sep; 77(12):1114-5. PubMed ID: 21880995
[No Abstract] [Full Text] [Related]
5. Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme.
Kerkhof M; Dielemans JC; van Breemen MS; Zwinkels H; Walchenbach R; Taphoorn MJ; Vecht CJ
Neuro Oncol; 2013 Jul; 15(7):961-7. PubMed ID: 23680820
[TBL] [Abstract][Full Text] [Related]
6. Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma.
Happold C; Gorlia T; Chinot O; Gilbert MR; Nabors LB; Wick W; Pugh SL; Hegi M; Cloughesy T; Roth P; Reardon DA; Perry JR; Mehta MP; Stupp R; Weller M
J Clin Oncol; 2016 Mar; 34(7):731-9. PubMed ID: 26786929
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid reduces hair loss and improves survival in patients receiving temozolomide-based radiation therapy for high-grade glioma.
Watanabe S; Kuwabara Y; Suehiro S; Yamashita D; Tanaka M; Tanaka A; Ohue S; Araki H
Eur J Clin Pharmacol; 2017 Mar; 73(3):357-363. PubMed ID: 27889835
[TBL] [Abstract][Full Text] [Related]
8. Antiepileptic drugs in patients with malignant brain tumor: beyond seizures and pharmacokinetics.
Gefroh-Grimes HA; Gidal BE
Acta Neurol Scand; 2016 Jan; 133(1):4-16. PubMed ID: 25996875
[TBL] [Abstract][Full Text] [Related]
9. Temozolomide in low-grade gliomas: living longer and better.
Rees J
J Neurol Neurosurg Psychiatry; 2015 Apr; 86(4):359-60. PubMed ID: 25189160
[No Abstract] [Full Text] [Related]
10. Current and Future Drug Treatments for Glioblastomas.
Ohba S; Hirose Y
Curr Med Chem; 2016; 23(38):4309-4316. PubMed ID: 27758718
[TBL] [Abstract][Full Text] [Related]
11. Fatal reactivation of hepatitis B with temozolomide.
Grewal J; Dellinger CA; Yung WK
N Engl J Med; 2007 Apr; 356(15):1591-2. PubMed ID: 17429098
[No Abstract] [Full Text] [Related]
12. Delirium likely caused by interaction between phenytoin and temozolomide.
Levy M
Psychosomatics; 2007; 48(4):359-60. PubMed ID: 17600176
[No Abstract] [Full Text] [Related]
13. Chemotherapy for malignant gliomas.
Marosi C
Wien Med Wochenschr; 2006 Jun; 156(11-12):346-50. PubMed ID: 16944366
[TBL] [Abstract][Full Text] [Related]
14. [The sodium pump could constitute a new target to combat glioblastomas].
Lefranc F; Mijatovic T; Kiss R
Bull Cancer; 2008 Mar; 95(3):271-81. PubMed ID: 18390407
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic radiotherapy for glioblastoma in the elderly.
Tartarone A; Ardito R; Romano C
N Engl J Med; 2007 Jul; 357(2):196; author reply 196. PubMed ID: 17626310
[No Abstract] [Full Text] [Related]
16. Seizure control: a secondary benefit of chemotherapeutic temozolomide in brain cancer patients.
Hu A; Xu Z; Kim RY; Nguyen A; Lee JW; Kesari S
Epilepsy Res; 2011 Aug; 95(3):270-2. PubMed ID: 21549564
[TBL] [Abstract][Full Text] [Related]
17. Unexpected case of aplastic anemia in a patient with glioblastoma multiforme treated with Temozolomide.
Jalali R; Singh P; Menon H; Gujral S
J Neurooncol; 2007 Oct; 85(1):105-7. PubMed ID: 17505778
[TBL] [Abstract][Full Text] [Related]
18. Status quo--standard-of-care medical and radiation therapy for glioblastoma.
Becker KP; Yu J
Cancer J; 2012; 18(1):12-9. PubMed ID: 22290252
[TBL] [Abstract][Full Text] [Related]
19. Adding concomitant and adjuvant temozolomide to radiotherapy does not reduce health-related quality of life in people with glioblastoma.
Hamilton DA
Cancer Treat Rev; 2006 Oct; 32(6):483-6. PubMed ID: 16730911
[No Abstract] [Full Text] [Related]
20. HDAC6 promotes cell proliferation and confers resistance to temozolomide in glioblastoma.
Wang Z; Hu P; Tang F; Lian H; Chen X; Zhang Y; He X; Liu W; Xie C
Cancer Lett; 2016 Aug; 379(1):134-42. PubMed ID: 27267806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
